Table 2.
Effect of GML on the serum anti-inflammatory and pro-inflammatory factors.
| Parameters | NCD | G400 | G800 | G1600 |
|---|---|---|---|---|
| TGF-β1 (ng mL−1) | 14.34 ± 6.98 | 14.08 ± 7.11 | 13.72 ± 7.25 | 23.32 ± 8.87 * |
| IL-22 (pg mL−1) | 25.42 ± 5.03 | 23.63 ± 1.60 | 21.52 ± 1.31 | 31.09 ± 2.59 * |
| IL-10 (pg mL−1) | 269.21 ± 131.29 | 369.26 ± 149.80 | 219.96 ± 183.82 | 147.65 ± 43.92 |
| TNFα (pg mL−1) | 22.23 ± 6.24 | 17.99 ± 7.98 | 19.63 ± 5.87 | 20.66 ± 7.63 |
| IL-6 (pg mL−1) | 28.95 ± 8.05 | 24.56 ± 8.01 | 29.19 ± 13.95 | 26.90 ± 12.56 |
| IL-1β (pg mL−1) | 13.20 ± 10.23 | 4.57 ± 3.80 | 8.03 ± 6.94 | 24.21 ± 12.26 |
| IL-12/p70 (pg mL−1) | 33.99 ± 9.78 | 32.10 ± 10.70 | 39.12 ± 14.85 | 37.95 ± 6.43 |
| IFNγ (pg mL−1) | 36.70 ± 2.00 | 38.97 ± 2.91 | 39.86 ± 3.33 | 40.28 ± 2.62 |
| LPS (U mL−1) | 11.18 ± 0.44 | 9.92 ± 4.72 | 11.11 ± 0.93 | 10.53 ± 0.77 |
| LBP (μg mL−1) | 1.59 ± 1.19 | 1.54 ± 0.81 | 1.55 ± 0.47 | 1.53 ± 0.58 |
Values were expressed as mean ± SD (n = 6–8). * p < 0.05 vs. NCD group.